16-1205223-G-A
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_021098.3(CACNA1H):c.2561G>A(p.Arg854Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000184 in 1,612,822 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R854W) has been classified as Likely benign.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_021098.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | NM_021098.3 | MANE Select | c.2561G>A | p.Arg854Gln | missense | Exon 11 of 35 | NP_066921.2 | ||
| CACNA1H | NM_001005407.2 | c.2561G>A | p.Arg854Gln | missense | Exon 11 of 34 | NP_001005407.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | TSL:1 MANE Select | c.2561G>A | p.Arg854Gln | missense | Exon 11 of 35 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | TSL:1 | c.2561G>A | p.Arg854Gln | missense | Exon 11 of 34 | ENSP00000454990.2 | ||
| CACNA1H | ENST00000711493.1 | c.2561G>A | p.Arg854Gln | missense | Exon 11 of 34 | ENSP00000518778.1 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152196Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000254 AC: 63AN: 248454 AF XY: 0.000296 show subpopulations
GnomAD4 exome AF: 0.000180 AC: 263AN: 1460508Hom.: 1 Cov.: 32 AF XY: 0.000197 AC XY: 143AN XY: 726488 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000223 AC: 34AN: 152314Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74478 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
CACNA1H: BS1, BS2
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at